QNRX Quoin Pharmaceuticals, Ltd.

Fundamentals / CIK 0001671502 / USD

Quoin Pharmaceuticals, Ltd. reported $34.75M in total assets and a net loss of $19.59M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open QNRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$20.07MFY 2019 Revenue: $0FY 2019 Net Income: -$1.56M2019FY 2020 Revenue: $0FY 2020 Net Income: -$2.10M2020FY 2021 Revenue: $0FY 2021 Net Income: -$21.46M2021FY 2022 Net Income: -$9.38M2022FY 2023 Net Income: -$8.69M2023FY 2024 Net Income: -$8.96M2024FY 2025 Net Income: -$15.80M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- $0 $0 $0
Research & Development $9.80M $3.60M $3.31M $2.67M $1.56M $244K $46K
Selling, General & Admin $6.49M $5.93M $6.07M $6.58M $4.50M $1.43M $1.51M
Operating Income -$16.29M -$9.53M -- -- -- -- --
Interest Income $482K $558K -- $96K -- -- --
Interest Expense -- -- -- -- $1.09M $47K --
Income Before Tax -$15.80M -$8.96M -- -- -- -- --
Net Income -$15.80M -$8.96M -$8.69M -$9.38M -$21.46M -$2.10M -$1.56M
Basic EPS -- -- -- -- -$0.00 -$0.03 -$0.02
Diluted EPS -- -- -- -- -$0.00 -$0.03 -$0.02
Basic Shares Outstanding -- -- -- -- 33.08B 25.08B 25.08B
Diluted Shares Outstanding -- -- -- -- 33.08B 25.08B 25.08B

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.66M $3.63M $3.43M $3.10M $2.28M $2.05M $2.37M $1.05M
Selling, General & Admin $2.27M $1.85M $1.70M $1.42M $1.74M $1.74M $1.58M $1.35M
Interest Income $125K $101K $147K $172K $62K $103K $145K --
Net Income -$4.87M -$5.37M -$5.00M -$4.35M -$3.95M -$3.70M -$3.81M -$2.31M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.82M $3.62M $2.40M $2.86M $7.48M $324K
Short-Term Investments $14.93M $10.43M -- -- -- --
Cash & Short-Term Investments $18.75M $14.06M $2.40M $2.86M $7.48M $324K
Total Current Assets $20.01M $14.93M $11.29M $13.37M $8.20M $465K
Intangible Assets $383K $483K $583K $705K $809K $913K
Total Non-Current Assets $383K $783K $883K $1.09M $1.16M $913K
Total Assets $20.39M $15.71M $12.17M $14.46M $9.36M $1.38M
Accounts Payable $1.26M $906K $527K $606K $923K --
Other Current Liabilities $600K $600K $600K $600K -- --
Total Current Liabilities $5.55M $4.18M $3.58M $3.53M $4.58M --
Other Non-Current Liabilities $1.72M $2.32M $2.92M $3.52M -- --
Total Non-Current Liabilities $1.72M $2.32M $2.92M $3.52M $4.12M --
Total Liabilities $7.27M $6.50M $6.51M $7.05M $8.70M $7.99M
Common Stock $0 $0 $0 $0 -- --
Retained Earnings -$70.97M -$55.17M -$46.20M -$37.52M -$28.07M -$6.61M
Accumulated Other Comp. Income -$613 $55.20M $46.20M $37.50M $28.10M --
Total Stockholders' Equity $13.12M $9.20M $5.66M $7.41M $657K -$6.61M
Total Equity $13.12M $9.20M $5.66M $7.41M $657K -$6.61M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $10.10M $3.85M $3.12M $3.82M $1.83M $1.67M $3.82M $3.62M
Short-Term Investments $23.08M $6.95M $10.92M $14.93M -- -- -- $10.43M
Cash & Short-Term Investments $33.18M $10.80M $14.04M $18.75M $1.83M $1.67M $3.82M $14.06M
Total Current Assets $34.40M $11.64M $15.33M $20.01M $6.02M $8.48M $12.50M $14.93M
Intangible Assets $308K $333K $358K $383K $408K $433K $458K $483K
Total Non-Current Assets $347K $333K $358K $383K $408K $433K $458K $783K
Total Assets $34.75M $11.97M $15.69M $20.39M $6.42M $8.91M $12.96M $15.71M
Accounts Payable $1.58M $3.11M $1.78M $1.26M $1.86M $874K $644K $906K
Other Current Liabilities $600K $600K $600K $600K $600K $600K $600K $600K
Total Current Liabilities $4.78M $6.61M $5.35M $5.55M $5.76M $4.34M $4.86M $4.18M
Other Non-Current Liabilities $1.27M $1.42M $1.57M $1.72M $1.87M $2.02M $2.17M $2.32M
Total Non-Current Liabilities $1.27M $1.42M $1.57M $1.72M $1.87M $2.02M $2.17M $2.32M
Total Liabilities $6.05M $8.04M $6.92M $7.27M $7.64M $6.36M $7.03M $6.50M
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$86.21M -$81.34M -$75.97M -$70.97M -$66.62M -$62.67M -$58.98M -$55.17M
Accumulated Other Comp. Income $2.1K -$582 -$159 -$613 -- $62.70M $59.00M $55.20M
Total Stockholders' Equity $28.70M $3.93M $8.77M $13.12M -$1.21M $2.55M $5.93M $9.20M
Total Equity $28.70M $3.93M $8.77M $13.12M -$1.21M $2.55M $5.93M $9.20M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$15.80M -$8.96M -$8.69M -$9.38M -$21.46M -$2.10M -$1.56M
Stock-Based Compensation $1.15M $1.26M $1.09M $764K $0 -- --
Operating Cash Flow -$13.54M -$7.86M -$7.86M -$8.48M -$5.72M -$1.34M -$1.30M
Purchases of Investments -$12.26M -$17.25M -$18.09M -$9.90M -- -- --
Sales & Maturities of Investments $7.99M $15.37M $20.28M -- -- -- --
Investing Cash Flow -$4.28M -$1.89M $2.19M -$10.15M -$625K -$125K --
Common Stock Issued $18.61M $11.57M -- -- -- -- --
Financing Cash Flow $18.01M $10.97M $5.22M $14.01M $13.50M $1.79M $1.30M
Net Change in Cash $195K $1.22M -$459K -$4.62M $7.16M $324K -$40

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.87M -$5.37M -$5.00M -$4.35M -$3.95M -$3.70M -$3.81M -$2.31M
Stock-Based Compensation $484K $533K $445K $283K $182K $321K $360K $326K
Operating Cash Flow -$5.77M -$3.14M -$4.87M -$5.04M -$2.23M -$3.69M -$2.59M -$2.24M
Purchases of Investments -$21.09M -$982K -$981K -- -- -- -- -$6.00M
Sales & Maturities of Investments $5.00M $5.00M $5.10M $996K $2.54M $1.68M $2.77M $2.82M
Investing Cash Flow -$16.09M $4.02M $4.12M -$11.27M $2.54M $1.68M $2.77M -$3.18M
Financing Cash Flow $28.11M -$152K $56K $18.29M -$150K -$150K $23K $5.92M
Net Change in Cash $6.25M $721K -$694K $1.99M $162K -$2.15M $199K $507K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -120.5% -97.4% -153.4% -126.7% -3266.6% -- --
Return on Assets (ROA) -77.5% -57.1% -71.4% -64.9% -229.4% -152.1% --
Current Ratio 3.61x 3.57x 3.15x 3.79x 1.79x -- --
Quick Ratio 3.38x 3.36x 0.67x 0.81x 1.64x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -68.3% -474.6% -193.7% -120.5% -- -477.0% -176.3% -97.4%
Return on Assets (ROA) -56.4% -155.9% -108.3% -77.5% -214.3% -136.5% -80.6% -57.1%
Current Ratio 7.20x 1.76x 2.87x 3.61x 1.04x 1.95x 2.57x 3.57x
Quick Ratio 6.95x 1.63x 2.63x 3.38x 0.32x 0.38x 0.79x 3.36x
Source: SEC EDGAR CompanyFacts (CIK 0001671502) · from December 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal